Trial Profile
A Phase II/III, Open-Label, Multicenter, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥ 28 Weeks to < 36 Weeks Gestational Age
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 22 Mar 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- Sponsors Hospira
- 02 Apr 2015 New trial record